http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33196446

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Multicenter Study
endingPage 1909
issn 0923-7534
issueIdentifier 8
pageRange 1903-1909
publicationName Annals of oncology : official journal of the European Society for Medical Oncology
startingPage 1903
bibliographicCitation Zhang AY, Grogan JS, Mahon KL, Rasiah K, Sved P, Eisinger DR, Boulas J, Vasilaris A, Henshall SM, Stricker PD, Kench JG, Horvath LG. A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer. Ann Oncol. 2017 Aug 01;28(8):1903–9. doi: 10.1093/annonc/mdx247. PMID: 28486686.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0f0fa008ba238840bf680b8abb944fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da49a06a0dc89f4c376d588218bc231d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bd2d4333a035bff271910889b06df79
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d394cc0af7fd5633e514c33f826d11e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a110eb4a1cbc95e53751e3f3178110af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_140c062654aba29f81115dff9af1ca3a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e6c9a2d84e8a13585721a0da8b9874a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c56aafd64bb7a656acf26fd657660fb0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f827b48512a0ec65724f0d7f5a6f9e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7558b6a0e16a4845f9d7fc68ca29dbe0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad2e9986759dadcbdbd9e1199d38d54c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45fa5979c7e76d31622258e4e2716ca0
date 2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/28486686
https://doi.org/10.1093/annonc/mdx247
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846
https://portal.issn.org/resource/ISSN/0923-7534
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer
discusses http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0003559
http://id.nlm.nih.gov/mesh/M0471840
http://id.nlm.nih.gov/mesh/M0504569
http://id.nlm.nih.gov/mesh/M0009493
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D014408Q000378
http://id.nlm.nih.gov/mesh/D002352Q000378
http://id.nlm.nih.gov/mesh/D011471Q000378
http://id.nlm.nih.gov/mesh/D006023Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015331
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D011471Q000473
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D054392
http://id.nlm.nih.gov/mesh/D001706
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_23624f7e9de3bf08e704e89f9f47dcb4

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID563

Total number of triples: 52.